These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 29904067)
1. CDKN2A inhibits formation of homotypic cell-in-cell structures. Liang J; Fan J; Wang M; Niu Z; Zhang Z; Yuan L; Tai Y; Chen Z; Song S; Wang X; Liu X; Huang H; Sun Q Oncogenesis; 2018 Jun; 7(6):50. PubMed ID: 29904067 [TBL] [Abstract][Full Text] [Related]
2. Expression profiling identified IL-8 as a regulator of homotypic cell-in-cell formation. Ruan B; Wang C; Chen A; Liang J; Niu Z; Zheng Y; Fan J; Gao L; Huang H; Wang X; Sun Q BMB Rep; 2018 Aug; 51(8):412-417. PubMed ID: 30021676 [TBL] [Abstract][Full Text] [Related]
3. Loss of CDKN2A and p14ARF expression occurs frequently in human nonmelanoma skin cancers. Pacifico A; Goldberg LH; Peris K; Chimenti S; Leone G; Ananthaswamy HN Br J Dermatol; 2008 Feb; 158(2):291-7. PubMed ID: 18070208 [TBL] [Abstract][Full Text] [Related]
4. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Herzog CR; Noh S; Lantry LE; Guan KL; You M Mol Carcinog; 1999 Jun; 25(2):92-8. PubMed ID: 10365910 [TBL] [Abstract][Full Text] [Related]
5. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536 [TBL] [Abstract][Full Text] [Related]
6. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes. Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049 [TBL] [Abstract][Full Text] [Related]
7. Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. Wolter M; Reifenberger J; Blaschke B; Ichimura K; Schmidt EE; Collins VP; Reifenberger G J Neuropathol Exp Neurol; 2001 Dec; 60(12):1170-80. PubMed ID: 11764089 [TBL] [Abstract][Full Text] [Related]
8. Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer. Liu X; Yang J Front Oncol; 2023; 13():1242725. PubMed ID: 37637068 [TBL] [Abstract][Full Text] [Related]
9. FBXL16 is a novel E2F1-regulated gene commonly upregulated in p16INK4A- and p14ARF-silenced HeLa cells. Sato K; Kusama Y; Tategu M; Yoshida K Int J Oncol; 2010 Feb; 36(2):479-90. PubMed ID: 20043084 [TBL] [Abstract][Full Text] [Related]
10. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma. Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268 [TBL] [Abstract][Full Text] [Related]
11. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217 [TBL] [Abstract][Full Text] [Related]
12. The exogenous wild-type p14ARF gene induces growth arrest and promotes radiosensitivity in human lung cancer cell lines. Gao N; Hu YD; Cao XY; Zhou J; Cao SL J Cancer Res Clin Oncol; 2001; 127(6):359-67. PubMed ID: 11414196 [TBL] [Abstract][Full Text] [Related]
13. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma. Uenogawa K; Hatta Y; Arima N; Hayakawa S; Sawada U; Aizawa S; Yamamoto T; Takeuchi J Int J Mol Med; 2011 Nov; 28(5):835-9. PubMed ID: 21785817 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis]. Tang SH; Yang DH; Luo HS; Yu JP; Shu JC Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134 [TBL] [Abstract][Full Text] [Related]
15. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas. Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of p16INK4A and p14ARF in haematological malignancies. Lee YK; Park JY; Kang HJ; Cho HC Clin Lab Haematol; 2003 Aug; 25(4):233-7. PubMed ID: 12890162 [TBL] [Abstract][Full Text] [Related]
17. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas. Simão Tde A; Simões GL; Ribeiro FS; Cidade DA; Andreollo NA; Lopes LR; Macedo JM; Acatauassu R; Teixeira AM; Felzenszwalb I; Pinto LF; Albano RM Hum Exp Toxicol; 2006 Sep; 25(9):515-22. PubMed ID: 17017004 [TBL] [Abstract][Full Text] [Related]
18. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma. Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]